Anti-Dlx5 antibody [EPR4488]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(18 Publications)
Rabbit Recombinant Monoclonal DLX5 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 18 publications.
View Alternative Names
Homeobox protein DLX-5, DLX5
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Dlx5 antibody [EPR4488] (AB109737)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human brain tissue labelling Dlx5 with unpurified ab109737 at 1/100.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Dlx5 antibody [EPR4488] (AB109737)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-Dlx5 antibody [EPR4488] (ab109737) at 1/5000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
U87-MG cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 32 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Dlx5 antibody [EPR4488] (AB109737)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human astrocytoma tissue labelling Dlx5 with purified ab109737 at 1/1000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a goat anti-rabbit IgG H&L (HRP) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- WB
Lab
Western blot - Anti-Dlx5 antibody [EPR4488] (AB109737)
Blocking buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Dlx5 antibody [EPR4488] (ab109737) at 1/1000 dilution
All lanes:
GST and His tagged recombinant Human Dlx5 protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 32 kDa
Observed band size: 60 kDa
false
Exposure time: 3s
- WB
CiteAb
Western blot - Anti-Dlx5 antibody [EPR4488] (AB109737)
Dlx5 western blot using anti-Dlx5 antibody [EPR4488] ab109737. Publication image and figure legend from Twomey-Kozak, J., Desai, S., et al., 2020, Int J Mol Sci, PubMed 32650430.
ab109737 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109737 please see the product overview.
DLX5 knockdown results in reduced expression of hypertrophy/ossification-related genes and decreased apoptosis in BM-MSCs. Relative mRNA expression levels of (A) DLX5, early chondrogenesis markers (B) COL1 and (C) COL2, terminal hypertrophic differentiation and ossification-related markers (D) COL10, (E) BGLAP and (F) ALPL in DLX5 siRNA knockdown BM-MSCs vs Control-scrambled siRNA BM-MSCs. The mRNA expression results are displayed at the basal level (“Noninduced” black-colored bars in the graph) and then again after undergoing chondrogenesis (“Chondro-induced” white-colored bars in the graph) to confirm the retention of the genotype. N ≥ 3; *, p ≤ 0.05; **, p ≤ 0.01 relative to control BM-MSCs. (G) Caspase-3/7 immunofluorescent staining of DLX5 siRNA knockdown BM-MSCs vs. Control-scrambled siRNA BM-MSCs. Scale = 250 µm. (H) Western blot analysis of DLX5, cleaved caspase-3, and the respective actin loading controls in DLX5 siRNA knockdown BM-MSCs and Control-scrambled siRNA BM-MSCs. Bar graphs represent the mean densitometric intensities of bands, normalized to Actin loading control bands. Measurements were made using ImageJ software. N = 3; *, p ≤ 0.05; ***, p ≤ 0.005.
false
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Dlx5 antibody [EPR4488]
-
Anti-Dlx5 antibody [EPR4488] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Nucleic acids research 53: PubMed40705926
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genes & diseases 10:2097-2108 PubMed37492739
2023
Applications
Unspecified application
Species
Unspecified reactive species
Disease models & mechanisms 15: PubMed35833364
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 20:179-193 PubMed35663336
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:5019920 PubMed35280506
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 11:3354-3374 PubMed34249467
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33919218
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 46:788-802 PubMed32856377
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32650430
2020
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 14:245-251 PubMed32455154
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com